News and Comments


  Wednesday, December 18, 2013

When Amgen (AMGN) develops a drug, the wise King does whatever it takes to squeeze every drop of its therapeutic capability before submitting the new drug application (NDA) to the FDA for approval. The firm is rich in its science, scientists, pipeline of investigational products and its approved products. All the problems the firm encountered that analysts believed would erode its fortune, such as limiting the use of its growth factors did not impact the firm’s growth, but unveiled the character and culture that made the king deserve its throne.   More...


  Monday, December 09, 2013

Taking down Gilead (GILD) seems to be beyond the reach authors of tales intended to frighten investors into selling this outstanding stock. The attempts have been repetitive but short of success. Gilead is a stallion. Unlike stallions, the horses whose muscular superiority over other horses is genetically derived, Gilead’s power is acquired through a unique culture that embraces the power of intuition, self-confidence, common sense and courage. Using an optimal amount of faith, the firm turned intuition into inspiration and using courage and wisdom, the Stallion carried out inspired tasks fated unattainable by others.  More...

Recent Postings



Cytokinetics (CYTK) Sanofi (SNY) Elan (ELN) Intrexon (XON) Agenus (AGEN) Ariad (ARIA) Sarepta (SRPT) Human Genome Sciences (HGSI) CompuGen (CGEN) Vitae Pharmaceuticals (VTAE) Exelixis (EXEL) Theravance Bio Pharma (TBPH) JUNO (JUNO) REGULUS (RGLS) Onyx (ONXX) Bellicum (BLCM) GlaxoSmithKline (GSK) Global Cell Therapeutics (GBT) Sequenom (SQNM) Aimmune Therapeutics (AIMT) ISIS (ISIS) Advaxis (ADXS) NEKTAR (NKTR)) Array Pharmaceuticals (ARRY) Biocryst (BCRX) Micromet (MITI) Xoma (XOMA) Dynavax (DVAX) Bristol-Myers Squibb (BMY) Intercept (ICPT) ABBVIE (ABBV) ADVENTRIX (ANX) Incyte (INCY) BIOMARIN (BMRN) TOKAI (TKAOI) ARCA (ABIO) VANDA (VNDA) SERES THERAPEUTICS (MCRB) ACADIA (ACAD) Regeneron (REGN) Mirati Therapeutics (MRTX) NOVOCURE (NVCR) SUNESIS PHARMACEUTICALS (SNSS) Illumina (ILMN) Ridaforolimus Inovio (INO) Theravance (THRX) RenenxBio (RGNX) Spike Therapeutics (ONCE) Roche (RHHBY) Pluristem (PSTI) Benlysta (belimumab) Vertex (VRTX) Prolor Biotech (PBTH) Valeant Pharmaceuticals International (VRX) Herceptin Endometrial Cancer ZALTRAP™ OSI (OSIP) KERYX (KERX) Biogen Idec (BIIB) AERIE PHARMACEUTICALS AGOS (ARGS) Tysabri Merck (MRK) Gilead (GILD) IDERA (IDRA) Galena (GALE) Zerenex Intermune (ITMN) Revlimid (lenolidamide) C4 Therapeutics Amgen (AMGN) Rapamune PTC Therapeutics (PTCT) Ziofpharm (ZIOP) Editas (EDIT) Agenus (AGEN MODERNA AstraZeneca (AZN) ImmunoGen (IMGN) Alder Biopharmaceuticals (ALDR) Prosensa (RNA) Sanofi-Aventis (SAN) Abbott Laboratories (ABT) Seattle Genetics (SGEN) Jazz Pharmaceuticals (JAZZ) HALOZYME (HALO) Multiple Myeloma Idenix (IDIX) CEMPRA (CEMP) galapagos (GLPG) Human Longevity (HLI) CRISPR Therapeutics (CRSP) Auspex (ASPX) Genentech INNOVIVA (INVA) GUARDIAN HEALTH Adaptimmune (ADAP) ARGOS (ARGS) Trastuzumab-DM1 Velcade (bortezomib) Roche (ROCHE) Telaprevir Alnylam (ALNY) Sangamo (SGMO) Anadys (ANDS) NANTKWEST (NK) SYNTA (SNTA) Anacor (ANAC) Ionis (IONS) KITE (KITE) Dendreon (DNDN) Ocular Therapeutix (OCUL) Sanofi (SNA)